Nephrology Section, Department of Internal Medicine and Pediatrics, Ghent University Hospital, 9000 Ghent, Belgium.
Departments of Pediatrics and Medicine (Nephrology), University of California San Diego, La Jolla, CA 92093, USA.
Toxins (Basel). 2022 Mar 17;14(3):221. doi: 10.3390/toxins14030221.
The topic of uremic toxicity has received broad attention from the nephrological community over the past few decades. An aspect that is much less often considered is the possibility that the metabolic pathways that generate uremic toxins also may produce molecules that benefit body functions. Here, we discuss this dualism based on the example of tryptophan-derived metabolites, which comprise elements that are mainly toxic, such as indoxyl sulfate, kynurenine and kynurenic acid, but also beneficial compounds, such as indole, melatonin and indole-3-propionic acid, and ambivalent (beneficial for some aspects and harmful for others) compounds such as serotonin. This dualism can also be perceived at the level of the main receptor of the tryptophan-derived metabolites, the aryl hydrocarbon receptor (AHR), which has also been linked to both harm and benefit. We hypothesize that these beneficial effects are the reason why uremic toxin generation remained preserved throughout evolution. This duality is also not unique for the tryptophan-derived metabolites, and in this broader context we discuss the remote sensing and signaling theory (RSST). The RSST proposes that transporters (e.g., organic anion transporter 1-OAT1; ATP-binding cassette transporter G-ABCG2) and drug metabolizing enzymes form a large network of proteins interacting to promote small molecule remote communication at the inter-organ (e.g., gut-liver-heart-brain-kidney) and inter-organismal (e.g., gut microbe-host) levels. These small molecules include gut microbe-derived uremic toxins as well as beneficial molecules such as those discussed here. We emphasize that this positive side of uremic metabolite production needs more attention, and that this dualism especially needs to be considered when assessing and conceiving of therapeutic interventions. These homeostatic considerations are central to the RSST and suggest that interventions be aimed at preserving or restoring the balance between positive and negative components rather than eliminating them all without distinction.
在过去的几十年里,尿毒症毒性这一课题受到了肾脏病学界的广泛关注。但人们很少考虑到的是,产生尿毒症毒素的代谢途径也可能产生有益于身体功能的分子。在这里,我们将以色氨酸衍生代谢物为例,讨论这种双重性,其中包括主要有毒的元素,如吲哚硫酸、犬尿氨酸和犬尿喹啉酸,以及有益的化合物,如吲哚、褪黑素和吲哚-3-丙酸,以及有双重作用(对某些方面有益,对其他方面有害)的化合物,如 5-羟色胺。这种双重性也可以在色氨酸衍生代谢物的主要受体——芳香烃受体(AHR)的水平上被感知,该受体也与伤害和益处有关。我们假设,这些有益的影响是尿毒症毒素在整个进化过程中得以保留的原因。这种双重性也不仅限于色氨酸衍生代谢物,在更广泛的背景下,我们将讨论远程传感和信号理论(RSST)。RSST 提出,转运蛋白(如有机阴离子转运蛋白 1-OAT1;ATP 结合盒转运蛋白 G-ABCG2)和药物代谢酶形成一个庞大的蛋白质网络,相互作用以促进小分子在器官间(如肠道-肝脏-心脏-大脑-肾脏)和机体间(如肠道微生物-宿主)的远程通讯。这些小分子包括肠道微生物衍生的尿毒症毒素以及这里讨论的有益分子。我们强调,尿毒症代谢产物产生的这种积极方面需要更多的关注,并且在评估和构思治疗干预措施时,这种双重性尤其需要考虑。这些动态平衡的考虑是 RSST 的核心,这表明干预措施应旨在保持或恢复正负成分之间的平衡,而不是不加区分地全部消除。